ProKidney (MEX:PROK) Buildings And Improvements : MXN373.25 Mil (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is ProKidney Buildings And Improvements?

ProKidney's quarterly buildings and improvements declined from Sep. 2023 (MXN391.75 Mil) to Dec. 2023 (MXN381.75 Mil) and declined from Dec. 2023 (MXN381.75 Mil) to Mar. 2024 (MXN373.25 Mil).

ProKidney's annual buildings and improvements stayed the same from Dec. 2021 (MXN0.00 Mil) to Dec. 2022 (MXN0.00 Mil) but then increased from Dec. 2022 (MXN0.00 Mil) to Dec. 2023 (MXN381.75 Mil).

ProKidney Buildings And Improvements Historical Data

The historical data trend for ProKidney's Buildings And Improvements can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ProKidney Buildings And Improvements Chart

ProKidney Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Buildings And Improvements

381.75

ProKidney Quarterly Data
	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Buildings And Improvements	Get a 7-Day Free Trial									-	-	391.75	381.75	373.25

ProKidney Buildings And Improvements Calculation

Buildings are typically valued at the time of acquisition or construction. Broker and architect fees, permits, etc. can be covered within this category. Building components, such as a roof, are normally recorded separately in an asset register since the value and useful lives of these components equal much less than the building itself.

Building improvements that extend the useful life of a building will fall into the category of “building improvements” and should be capitalized. Improvements are commonly recorded at acquisition cost. Building improvement examples include roofing, remodeling, replacements, etc.

ProKidney (MEX:PROK) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ProKidney Corp (MEX:PROK) » Definitions » Buildings And Improvements

Comparable Companies

Traded in Other Exchanges

PROK:USA

Address

2000 Frontis Plaza Boulevard, Suite 250, Winston-Salem, NC, USA, 27103

Website

https://www.prokidney.com

ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's own cells isolated from the patient intended for treatment. Its lead product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's own renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease.